Current therapeutic targets for Alzheimer's disease
Alzheimer's disease (AD) is one of the most common multifactorial diseases, including a
range of abnormal cellular/molecular processes occurring in different regions of the brain …
range of abnormal cellular/molecular processes occurring in different regions of the brain …
[HTML][HTML] Recent advances in the neurobiology and neuropharmacology of Alzheimer's disease
K Kumar, A Kumar, RM Keegan… - Biomedicine & …, 2018 - Elsevier
Alzheimer's disease (AD) is an age-related neurodegenerative disorder characterized by
progressive deterioration of cognitive functions. The pathological hallmarks are extracellular …
progressive deterioration of cognitive functions. The pathological hallmarks are extracellular …
A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease
M Kashif, P Sivaprakasam, P Vijendra… - Current …, 2023 - ingentaconnect.com
Aim: Alzheimer's disease (AD) has been identified as a progressive brain disorder
associated with memory dysfunction and the accumulation of β-amyloid plaques and …
associated with memory dysfunction and the accumulation of β-amyloid plaques and …
Novel insights for the treatment of Alzheimer's disease
A Kurz, R Perneczky - Progress in Neuro-Psychopharmacology and …, 2011 - Elsevier
The development of treatments for Alzheimer's disease (AD) is currently shifting away from
the correction of neurotransmitter abnormalities and from attempts to remove the …
the correction of neurotransmitter abnormalities and from attempts to remove the …
Therapeutic perspectives in Alzheimer's disease
JA Tschape, T Hartmann - Recent Patents on CNS Drug …, 2006 - ingentaconnect.com
It is now almost a century ago that Alois Alzheimer first presented his results in public. Main
characteristics of Alzheimer's disease (AD) are massive cerebral accumulation of amyloid …
characteristics of Alzheimer's disease (AD) are massive cerebral accumulation of amyloid …
A review on advances of treatment modalities for Alzheimer's disease
Alzheimer's disease (AD) is a multifactorial neurodegenerative disease which is mainly
characterized by progressive impairment in cognition, emotion, language and memory in …
characterized by progressive impairment in cognition, emotion, language and memory in …
New possibilities in the therapeutic approach to Alzheimer's disease
J Doroszkiewicz, B Mroczko - International Journal of Molecular Sciences, 2022 - mdpi.com
Despite the fact that Alzheimer's disease (AD) is the most common cause of dementia, after
many years of research regarding this disease, there is no casual treatment. Regardless of …
many years of research regarding this disease, there is no casual treatment. Regardless of …
[PDF][PDF] Alzheimer's disease: current status of etiopathogenesis and therapeutic strategies
MI Khairallah, LAA Kassem - Pakistan Journal of Biological Sciences, 2011 - academia.edu
Alzheimer's Disease (AD) is one of the most common age-related neurodegenerative
diseases. It is the most prevalent form of dementia, a general term for memory loss. It is …
diseases. It is the most prevalent form of dementia, a general term for memory loss. It is …
Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions
A Dey, R Bhattacharya, A Mukherjee… - Biotechnology advances, 2017 - Elsevier
Alzheimer's disease (AD) is a severe, chronic and progressive neurodegenerative disease
associated with memory and cognition impairment ultimately leading to death. It is the …
associated with memory and cognition impairment ultimately leading to death. It is the …
[HTML][HTML] An update on the novel and approved drugs for Alzheimer disease
HA Alhazmi, M Albratty - Saudi Pharmaceutical Journal, 2022 - Elsevier
Introduction Given the severity of the condition and the increasing number of patients,
developing effective therapies for Alzheimer's disease has become a significant necessity …
developing effective therapies for Alzheimer's disease has become a significant necessity …